期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 16, 期 2, 页码 762-770出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2007.10.040
关键词
-
资金
- NIDDK NIH HHS [R01 DK052798, R01 DK052798-06, R01 DK052798-07, DK-52798, R56 DK052798, R01 DK052798-05, R01 DK052798-09, R01 DK052798-08] Funding Source: Medline
Analogs of the TR alpha-specific thyromimetic CO23 were synthesized and analyzed in vitro using competitive binding and transactivation assays. Like CO23, all analogs bind to both thyroid hormone receptor subtypes with about the same affinity; however, modification of CO23 by derivatization of the 3' position of the outer-ring or replacement of the inner-ring iodides with bromides attenuates binding. Despite lacking a preference in binding to TR alpha, all analogs display TR alpha-specificity in transactivation assays using U2OS and HeLa cells. At best, several agonists exhibit an approximately 6-12-fold preference in transactivation when tested with TR alpha in HeLa cells. One analog, CO24, showed in vivo TR alpha-specific action in a tadpole metamorphosis assay. (c) 2007 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据